# Modulation of p53 activity by IκBα: Evidence suggesting a common phylogeny between NF-κB and p53 transcription factors

**Authors:** David H Dreyfus, Masayuki Nagasawa, Erwin W Gelfand, Lucy Y Ghoda

PMC · DOI: 10.1186/1471-2172-6-12 · BMC Immunology · 2005-06-21

## TL;DR

This paper suggests that p53 and NF-κB, two key proteins in cell regulation, may have evolved from a common ancestor due to similarities in structure and function.

## Contribution

The study provides evidence for a possible evolutionary relationship between p53 and NF-κB through structural and functional similarities.

## Key findings

- p53 and NF-κB share 8 out of 10 nucleotides in their DNA binding sequences.
- IκBα can inhibit p53 transcriptional activity through direct or cooperative binding.
- Structural and functional similarities suggest a common ancestry between p53 and NF-κB.

## Abstract

In this work we present evidence that the p53 tumor suppressor protein and NF-κB transcription factors could be related through common descent from a family of ancestral transcription factors regulating cellular proliferation and apoptosis. P53 is a homotetrameric transcription factor known to interact with the ankyrin protein 53BP2 (a fragment of the ASPP2 protein). NF-κB is also regulated by ankyrin proteins, the prototype of which is the IκB family. The DNA binding sequences of the two transcription factors are similar, sharing 8 out of 10 nucleotides. Interactions between the two proteins, both direct and indirect, have been noted previously and the two proteins play central roles in the control of proliferation and apoptosis.

Using previously published structure data, we noted a significant degree of structural alignment between p53 and NF-κB p65. We also determined that IκBα and p53 bind in vitro through a specific interaction in part involving the DNA binding region of p53, or a region proximal to it, and the amino terminus of IκBα independently or cooperatively with the ankyrin 3 domain of IκBα In cotransfection experiments, κBα could significantly inhibit the transcriptional activity of p53. Inhibition of p53-mediated transcription was increased by deletion of the ankyrin 2, 4, or 5 domains of IκBα Co-precipitation experiments using the stably transfected ankyrin 5 deletion mutant of κBα and endogenous wild-type p53 further support the hypothesis that p53 and IκBα can physically interact in vivo.

The aggregate results obtained using bacterially produced IκBα and p53 as well as reticulocyte lysate produced proteins suggest a correlation between in vitro co-precipitation in at least one of the systems and in vivo p53 inhibitory activity. These observations argue for a mechanism involving direct binding of IκBα to p53 in the inhibition of p53 transcriptional activity, analogous to the inhibition of NF-κB by κBα and p53 by 53BP2/ASPP2. These data furthermore suggest a role for ankyrin proteins in the regulation of p53 activity. Taken together, the NFκB and p53 proteins share similarities in structure, DNA binding sites and binding and regulation by ankyrin proteins in support of our hypothesis that the two proteins share common descent from an ancestral transcriptional factor.

## Linked entities

- **Genes:** TP53 (tumor protein p53) [NCBI Gene 7157], NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790], NFKBIA (NFKB inhibitor alpha) [NCBI Gene 4792], TP53BP2 (tumor protein p53 binding protein 2) [NCBI Gene 7159], TP53BP2 (tumor protein p53 binding protein 2) [NCBI Gene 7159]
- **Proteins:** TP53 (tumor protein p53), NFKB1 (nuclear factor kappa B subunit 1), NFKBIA (NFKB inhibitor alpha), TP53BP2 (tumor protein p53 binding protein 2), TP53BP2 (tumor protein p53 binding protein 2)

## Full-text entities

- **Genes:** RPS6KA1 (ribosomal protein S6 kinase A1) [NCBI Gene 6195] {aka HU-1, MAPKAPK1, MAPKAPK1A, RSK, RSK1, p90Rsk}, REL (REL proto-oncogene, NF-kB subunit) [NCBI Gene 5966] {aka C-Rel, HIVEN86A, IMD92}, Trp53-ps (transformation related protein 53, pseudogene) [NCBI Gene 22060], Ighv2-3 (immunoglobulin heavy variable 2-3) [NCBI Gene 238412] {aka Gm16948}, NFKBIA (NFKB inhibitor alpha) [NCBI Gene 4792] {aka EDAID2, IKBA, MAD-3, NFKBI}, cact (cactus) [NCBI Gene 34969] {aka 5848, BG:DS02740.15, CACTUS, CG5848, Cactus, Dmel\CG5848}, MDM2 (MDM2 proto-oncogene) [NCBI Gene 4193] {aka ACTFS, HDMX, LSKB, hdm2}, ASS1P2 (argininosuccinate synthetase 1 pseudogene 2) [NCBI Gene 447] {aka ASSP2}, unc-22 (Twitchin;non-specific serine/threonine protein kinase) [NCBI Gene 178135], NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, ANK3 (ankyrin 3) [NCBI Gene 288] {aka ANKYRIN-G, MRT37}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, Hc (hemolytic complement) [NCBI Gene 15139] {aka C5, C5a, He, Hfib2}, BZLF1 (protein Zta) [NCBI Gene 3783744], Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, H3P16 (H3 histone pseudogene 16) [NCBI Gene 644914] {aka H3.6, H3F3AP6, p21}, PRL (prolactin) [NCBI Gene 5617] {aka GHA1, pPRL}, JUN (Jun proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 3725] {aka AP-1, AP1, c-Jun, cJUN, p39}, TP53BP2 (tumor protein p53 binding protein 2) [NCBI Gene 7159] {aka 53BP2, ASPP2, BBP, P53BP2, PPP1R13A}, PSMD10 (proteasome 26S subunit, non-ATPase 10) [NCBI Gene 5716] {aka dJ889N15.2, p28, p28(GANK)}, Rela (Rela proto-oncogene, NFKB subunit) [NCBI Gene 19697] {aka p65, p65 NF-kappa B, p65 NFkB}, TP53BP1 (tumor protein p53 binding protein 1) [NCBI Gene 7158] {aka 53BP1, TDRD30, p202, p53BP1}, p53 (p53) [NCBI Gene 2768677] {aka CG10873, CG31325, CG33336, D-p53, DMP53, Dm-P53}, Nfkbia (nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha) [NCBI Gene 18035] {aka Nfkbi}, RELA (RELA proto-oncogene, NF-kB subunit) [NCBI Gene 5970] {aka AIF3BL3, CMCU, NFKB3, p65}, NFKBIB (NFKB inhibitor beta) [NCBI Gene 4793] {aka IKBB, TRIP9}, HERC1 (HECT and RLD domain containing E3 ubiquitin protein ligase family member 1) [NCBI Gene 8925] {aka MDFPMR, p532, p619}, tp53.L (tumor protein p53 L homeolog) [NCBI Gene 397926] {aka Trp248, Xp53, Xrel3, p53, tp53}
- **Diseases:** Burkitts lymphoma (MESH:D002051), melanoma (MESH:D008545), hereditary syndromes (MESH:D009386), CMV (MESH:D003586), DHD (MESH:C535602), inflammation (MESH:D007249), malignancies (MESH:D009369), herpesvirus infection (MESH:D006566), papilloma (MESH:D010212)
- **Species:** Xenopus laevis (African clawed frog, species) [taxon 8355], Oryctolagus cuniculus (domestic rabbit, species) [taxon 9986], Mus musculus (house mouse, species) [taxon 10090], Drosophila melanogaster (fruit fly, species) [taxon 7227], C. elegans [taxon 328850], human gammaherpesvirus 4 (Epstein Barr virus, no rank) [taxon 10376], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Homo sapiens (human, species) [taxon 9606], Chlorocebus aethiops (African green monkey, species) [taxon 9534]
- **Mutations:** V193A, Gly-Ala
- **Cell lines:** A2085 — Homo sapiens (Human), Bloom syndrome, Finite cell line (CVCL_U703), RRL — Oryctolagus cuniculus (Rabbit), Finite cell line (CVCL_DR19), COS — Chlorocebus aethiops (Green monkey), Transformed cell line (CVCL_0223), Chang — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0238), Akata — Homo sapiens (Human), EBV-related Burkitt lymphoma, Cancer cell line (CVCL_VN89), pC53 — Homo sapiens (Human), Pancreatic carcinoma, Cancer cell line (CVCL_4011), pCEP4 — Homo sapiens (Human), Natural killer cell lymphoblastic leukemia/lymphoma, Cancer cell line (CVCL_U271)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC1184076/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC1184076/full.md

## References

81 references — full list in the complete paper: https://tomesphere.com/paper/PMC1184076/full.md

---
Source: https://tomesphere.com/paper/PMC1184076